|
Jul 1
|
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
|
|
Jun 20
|
Penumbra may gain market share in peripheral embolisation coils with Ruby XL
|
|
Jun 20
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 20
|
The Top 5 Analyst Questions From Penumbra’s Q1 Earnings Call
|
|
Jun 19
|
There's Been No Shortage Of Growth Recently For Penumbra's (NYSE:PEN) Returns On Capital
|
|
Jun 19
|
Winners And Losers Of Q1: Penumbra (NYSE:PEN) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
|
|
Jun 19
|
ICU Medical (NASDAQ:ICUI): Strongest Q1 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group
|
|
Jun 17
|
Penumbra completes enrolment in trial for pulmonary embolism
|
|
Jun 16
|
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
|
|
May 14
|
Here's Why Penumbra (PEN) is a Strong Growth Stock
|
|
May 13
|
Dow Jones Software Giant Microsoft Stock Hits New Buy Point After Big Earnings Move
|
|
May 13
|
1 High-Flying Stock on Our Buy List and 2 to Avoid
|
|
Apr 15
|
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
|
|
Mar 15
|
Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls
|
|
Feb 28
|
Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail
|
|
Feb 28
|
3 Mid-Cap Stocks in Hot Water
|
|
Feb 22
|
Penumbra, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
|
|
Feb 21
|
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
|
|
Feb 20
|
Penumbra (PEN) Upgraded to Buy: Here's Why
|
|
Feb 20
|
Penumbra Full Year 2024 Earnings: EPS Misses Expectations
|